Disease activity, health status and quality of life in patients with ankylosing spondylitis associated with fibromyalgia

Keywords: ankylosing spondylitis, fibromyalgia, comorbidity.

Abstract

Annotation. Ankylosing spondylitis (AS) and fibromyalgia (FM) are often comorbid pathological conditions, and the presence of FM, which characterized by the complexity of diagnosis and treatment, may be one of the factors delaying the diagnosis of AS. FM can also complicate the interpretation of disease activity, assessment of pain and the choice of adequate anti-inflammatory therapy, which makes it essential to study the impact of this comorbidity on the clinical course of AS. The study aimed to evaluate the indicators of disease activity, health, and quality of life of patients with AS associated with FM. One hundred forty-three patients with AS (81.8% of men) aged 42.1±11.3 years (M ± σ) were examined. The diagnosis of AS was established according to modified New York criteria (1984), and the diagnosis of FM – by the criteria of mACR2010. FM detected in 49 (34.3%) individuals. Indicators of disease activity (ASDAS-ESR, BASDAI), functional status (BASMI, BASFI), quality of life and health (ASQoL, ASAS HI/EF, HAQ), fatigue, sleep disorders, depressive and cognitive disorders (MAF, PSQI, HAM-D, MMSE) was determined. The study was conducted in compliance with bioethical standards. Statistical processing of the results was performed using IBM Statistics SPSS 22. Patients with concomitant FM showed higher rates of disease activity by BASDAI and poorer functional ability by BASFI and BASMI (by 30.2%; 53.2% and 33.2%, p<0.01), by ASDAS-ESR (by 11,5%, p<0.05). Among patients with FM, individuals with very high disease activity (BASDAI≥6.0), significant functional disorders (BASFI≥4.0 and BASMI≥4.0) were more likely than among patients without FM (1.97; 1,69 and 1.73 times, p <0.001, respectively). Patients with AS with FM showed worse health and quality of life indicators for ASQoL, HAQ and ASAS HI (65.2%; 34.7% and 26.4%, p<0.001). Moderate and severe fatigue (MAF ≥ 20), sleep disorders (PSQI ≥ 5) and depressive disorders (HAM-D ≥ 8) were in 75.5%; 68.1% and 60.6% of patients without FM and in 98%; 100% and 98% (p<0.001) of patients with FM. There are direct correlations between the severity of polysymptomatic distress and the BASDAI, BASFI and ASAS HI indices (r = 0.52; 0.57 and 0.42, p<0.001). So, patients with AS with FM characterized by higher disease activity, more insufficient functional ability and lower quality of life.

Downloads

Download data is not yet available.

References

[1] Aloush, V., Ablin, J. N., Reitblat, T., Caspi, D., & Elkayam, O. (2007). Fibromyalgia in women with ankylosing spondylitis. Rheumatology international, 27(9), 865-868. doi: 10.1007/s00296-007-0344-3
[2] Amiri, A. H., & Sedighi, O. (2014). Prevalence of fibromyalgia in patients with ankylosing spondylitis. Medical Journal of Dr. DY Patil University, 7(3), 338. DOI: 10.4103/0975-2870.128977
[3] Atzeni, F., Boccassini, L., Di Franco, M., Alciati, A., Marsico, A., Cazzola, M., ... & Sarzi-Puttini, P. (2014). Chronic widespread pain in spondyloarthritis. Reumatismo, 66(1), 28-32. doi: 10.4081/reumatismo.2014.761
[4] Barnett, R., Ingram, T., & Sengupta, R. (2020). Axial spondyloarthritis 10 years on: still looking for the lost tribe. Rheumatology, 59(4), iv25-iv37. https://doi.org/10.1093/rheumatology/keaa472
[5] Bedaiwi, M., Sari, I., Thavaneswaran, A., Ayearst, R., Haroon, N., & Inman, R. D. (2015). Fatigue in ankylosing spondylitis and nonradiographic axial spondyloarthritis: analysis from a longitudinal observation cohort. The Journal of rheumatology, 42(12), 2354-2360. doi: 10.3899/jrheum.150463
[6] Belza, B., Miyawaki, C. E., Liu, M., Aree-Ue, S., Fessel, M., Minott, K. R., & Zhang, X. (2018). A systematic review of studies using the Multidimensional Assessment of Fatigue scale. Journal of Nursing Measurement, 26(1), 36-74. doi: 10.1891/1061-3749.26.1.36
[7] Bijlsma, J. (2018). EULAR textbook on rheumatic diseases. (3rd ed.). BMJ Publishing Group.
[8] Branco, J. C., Bannwarth, B., Failde, I., Carbonell, J. A., Blotman, F., Spaeth, M., ... & Le Lay, K. (2010). Prevalence of fibromyalgia: a survey in five European countries. In Seminars in arthritis and rheumatism, 39 (6), 448-453. doi: 10.1016/j.semarthrit.2008.12.003
[9] Bruce, B., & Fries, J. F. (2005). The health assessment questionnaire (HAQ). Clinical and experimental rheumatology, 23(5), 14.
[10] Buysse, D. J., Reynolds, C. F., Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. The Psychiatric Res., 28(2), 193-213. doi: 10.1016/0165-1781(89)90047-4
[11] Calin, A., Garrett, S., Whitelock, H., Kennedy, L. G., O'hea, J., Mallorie, P., & Jenkinson, T. (1994). A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of rheumatology, 21(12), 2281-2285.
[12] Crichton, N. (2001). Visual analogue scale (VAS). J Clin Nurs, 10(5), 706-6.
[13] Doward, L., Spoorenberg, A., Cook, S. A., Whalley, D., Helliwell, P. S., Kay, L. J., ... & Chamberlain, M. A. (2003). Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis. Annals of the rheumatic diseases, 62(1), 20-26. doi: 10.1136/ard.62.1.20
[14] Fan, A., Tournadre, A., Pereira, B., Tatar, Z., Couderc, M., Malochet-Guinamand, S., ... & Dubost, J. J. (2016). Performance of Fibromyalgia Rapid Screening Tool (FiRST) to detect fibromyalgia syndrome in rheumatic diseases. Rheumatology, 55(10), 1746-1750. doi: 10.1093/rheumatology/kew244
[15] Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. Journal of psychiatric research, 12(3), 189-198. doi: 10.1016/0022-3956(75)90026-6
[16] Gareth, T. J., Mallawaarachchi, B.hadra, M., Shim, J.oanna, S., Lock, JonathanJ., L., & Macfarlane, Gary, J. M. (2020). The Prevalence of Fibromyalgia in Axial Spondyloarthritis. Rheumatology international, 40(10), 1581-1591. doi: 10.1007/s00296-020-04621-5
[17] Garrett, S., Jenkinson, T., Kennedy, L. G., Whitelock, H., Gaisford, P., & Calin, A. (1994). A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol., 21(12), 2286-2291.
[18] Hamilton, M. A. X. (1967). Development of a rating scale for primary depressive illness. British journal of social and clinical psychology, 6(4), 278-296. https://doi.org/10.1111/j.2044-8260.1967.tb00530.x
[19] Jenkinson, T. R., Mallorie, P. A., Whitelock, H. C., Kennedy, L. G., Garrett, S. L., & Calin, A. (1994). Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index. The Journal of rheumatology, 21(9), 1694-1698.
[20] Jones, S. D., Porter, J., Garrett, S. L., Kennedy, L. G., Whitelock, H., & Calin, A. (1995). A new scoring system for the Bath Ankylosing Spondylitis Metrology Index (BASMI). The Journal of Rheumatology, 22(8), 1609.
[21] Jones, S. D., Steiner, A., Garrett, S. L., & Calin, A. (1996). The bath ankylosing spondylitis patient global score (BAS-G). Rheumatology, 35(1), 66-71. doi: 10.1093/rheumatology/35.1.66
[22] Kiltz, U., van der Heijde, D., Boonen, A., Akkoc, N., Bautista-Molano, W., Burgos-Vargas, R., ... & Braun, J. (2018). Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis. Annals of the rheumatic diseases, 77(9), 1311-1317. doi: 10.1136/annrheumdis-2017-212076
[23] Kiltz, U., van der Heijde, D., Boonen, A., Cieza, A., Stucki, G., Khan, M. A., … & Braun, J. (2014). Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis., 0:1–6.
[24] Kiltz, U., van der Heijde, D., Cieza A., Boonen, A., Stucki, G., Ustün, B., & Braun, J. (2011). Developing and validating an index for measuring health in patients with ankylosing spondylitis. Rheumatology (Oxford), 50, 894-8. doi:10.1093/rheumatology/keq315
[25] Li, T., Zhou, L., Zhao, H., Song, J., Wang, X., Liu, S., & Xu, H. (2019). Fatigue in Ankylosing Spondylitis Is Associated With Psychological Factors and Brain Gray Matter. Frontiers in medicine, 6, 271. https://doi.org/10.3389/fmed.2019.00271
[26] Linden, S. V. D., Valkenburg, H. A., & Cats, A. (1984). Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis & Rheumatism, 27(4), 361-368. doi: 10.1002/art.1780270401
[27] López-Medina, C., & Moltó, A. (2020). Comorbid pain in axial spondyloarthritis, including fibromyalgia. Therapeutic Advances in Musculoskeletal Disease, 12, 1759720X20966123. doi: 10.1177/1759720X20966123
[28] Macfarlane, G. J., Rotariu, O., Jones, G. T., Pathan, E., & Dean, L. E. (2020). Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS). Annals of the rheumatic diseases, 79(2), 202-208. DOI: 10.1136/annrheumdis-2019-216143
[29] Machado, P., Landewé, R., Lie, E., Kvien, T. K., Braun, J., & Baker, D. (2011). Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores. Annals of the rheumatic diseases, 70(1), 47-53. doi: 10.1136/ard.2010.138594
[30] Mogard, E., Lindqvist, E., Bremander, A., & Bergman, S. (2019). Risk factors for development and persistence of chronic widespread pain in spondyloarthritis: a population-based two-year follow-up study. Scandinavian journal of rheumatology, 48(6), 460-468. doi: 10.1080/03009742.2019.1602163
[31] Nikiphorou, E., Ramiro, S., van der Heijde, D., Norton, S., Moltó, A., Dougados, M., ... & Landewe, R. (2018). Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study Task Force. R. Association of comorbidities in spondyloarthritis with poor function, work disability, and quality of life: results from the Assessment of SpondyloArthritis International Society Comorbidities in Spondyloarthritis Study. Arthritis care & research, 70(8), 1257-1262. doi: 10.1002/acr.23468
[32] Ogdie, A., Nowell, W. B., Reynolds, R., Gavigan, K., Venkatachalam, S., de la Cruz, M., ... & Park, Y. (2019). Real-world patient experience on the path to diagnosis of ankylosing spondylitis. Rheumatology and therapy, 6(2), 255-267. doi: 10.1007/s40744-019-0153-7.
[33] Perebetyuk, L. S., & Stanislavchuk, M. A. (2015). Поширеність та клінічні особливості фіброміалгії за критеріями ACR1990, mACR2010 та шкалою SIQR в українській когорті хворих на ревматоїдний артрит [Prevalence and clinical features of fibromyalgia according to criteria ACR1990, mACR2010 and SIQR scale in the Ukrainian cohort of patients with rheumatoid arthritis]. Український ревматологічний журнал – Ukrainian Journal of Rheumatology, 3, 40-45.
[34] Rençber, N., Saglam, G., & Hüner, B. (2019). Presence of fibromyalgia syndrome and its relationship with clinical parameters in patients with axial spondyloarthritis. Pain physician, 22(6), E579-E585.
[35] Roussou, E., & Ciurtin, C. (2012). Clinical overlap between fibromyalgia tender points and enthesitis sites in patients with spondyloarthritis who present with inflammatory back pain. Clin Exp Rheumatol., 30(6, 74), 24-30.
[36] Salaffi, F., De Angelis, R., Carotti, M., Gutierrez, M., Sarzi-Puttini, P., & Atzeni, F. (2014). Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity. Rheumatology international, 34(8), 1103-1110. doi: 10.1007/s00296-014-2955-9
[37] Stanislavchuk, M. A., Shapoval, I. I., & Zaichko, K. O. (2016). Адаптація та валідизація україномовної версії ASAS Health Index and Environmental Factors у хворих на анкілозивний спондилоартрит [Adaptation and validation of the Ukrainian version of the ASAS Health Index and Environmental Factors in patients with ankylosing spondylitis]. Український ревматологічний журнал – Ukrainian Journal of Rheumatology, 65(3), 55-58.
[38] Wolfe, F., Clauw, D. J., Fitzcharles, M. A., Goldenberg, D. L., Häuser, W., Katz, R. S., ... & Winfield, J. B. (2011). Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. The Journal of rheumatology, 38(6), 1113-1122. doi: 10.3899/jrheum.100594
Published
2021-03-27
How to Cite
ShapovalІ. І. (2021). Disease activity, health status and quality of life in patients with ankylosing spondylitis associated with fibromyalgia. Reports of Vinnytsia National Medical University, 25(1), 165-170. https://doi.org/10.31393/reports-vnmedical-2021-25(1)-29
Section
SOCIAL MEDICINE, ORGANIZATION OF HEALTH PROTECTION